Antibodies against interferon-beta in multiple sclerosis.
about
Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune ComplexesImmunogenicity to biologics: mechanisms, prediction and reduction.Deficient phosphorylation of Stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-betaAnalyses of the pathways involved in early- and late-phase induction of IFN-beta during C. muridarum infection of oviduct epithelial cellsTreatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients.Use of a standardized MxA protein measurement-based assay for validation of assays for the assessment of neutralizing antibodies against interferon-β.Determinants of interferon β efficacy in patients with multiple sclerosis.Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals.Applications of cell-based bioassays measuring the induced expression of endogenous genes.Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis.Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
P2860
Q26766424-28041A0C-3B24-4940-80BB-C2779815393BQ34296526-BD31C709-5482-49D0-8160-7D6069593C59Q35106187-364A1054-46C3-4391-9FBA-6491FBA192A0Q35208728-97686E50-FE61-476E-B917-BC1AB5155CE5Q37223201-1B06FAA8-0105-465A-832B-077B6EE2280CQ37272709-03CBFE10-32A0-4ED8-B656-7FE5F79739BEQ37848651-5C9E6A92-65DC-4FD1-AA9E-CA76AAB2532AQ38046653-03BEB39E-CD48-432D-9E2F-3A5CD41218B7Q38232126-A9409E0A-24E9-48B9-A506-4F5B4CDC2E69Q39404622-022A25A9-A4AB-4204-9481-E18EAE40D84AQ44805804-8CAE65C5-2885-4F46-A3AF-397BFE096433Q47819826-3384B0A1-3F05-406B-97C0-10A36FCA3526
P2860
Antibodies against interferon-beta in multiple sclerosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antibodies against interferon-beta in multiple sclerosis.
@ast
Antibodies against interferon-beta in multiple sclerosis.
@en
Antibodies against interferon-beta in multiple sclerosis.
@nl
type
label
Antibodies against interferon-beta in multiple sclerosis.
@ast
Antibodies against interferon-beta in multiple sclerosis.
@en
Antibodies against interferon-beta in multiple sclerosis.
@nl
prefLabel
Antibodies against interferon-beta in multiple sclerosis.
@ast
Antibodies against interferon-beta in multiple sclerosis.
@en
Antibodies against interferon-beta in multiple sclerosis.
@nl
P2093
P1476
Antibodies against interferon-beta in multiple sclerosis.
@en
P2093
Christian A Vedeler
Nina Karin Aarskog
Tove Marøy
P304
P356
10.1016/J.JNEUROIM.2009.04.012
P577
2009-05-20T00:00:00Z